“Non-Essential” Research: Another Victim of the Coronavirus Pandemic

In February of this year, Michael Gentry had finally made a breakthrough. Gentry, a biochemist at The University of Kentucky College of Medicine, was racing to run animal experiments on a new enzymatic compound that fights Lafora disease. The promising drug was on track to enter human trials early in 2021.  Lafora disease is a neurodegenerative condition characterized by intellectual decline and recurring seizures. The … Continue reading “Non-Essential” Research: Another Victim of the Coronavirus Pandemic